Search

Author/Creator Tabak, F.

1. Alisporivir with peginterferon/ribavirin in patients with chronic hepatitis C genotype 1 infection who failed to respond to or relapsed after prior interferon‐based therapy: FUNDAMENTAL, a Phase II trial. Issue 7 (21st November 2014)

Authors:
Buti, M.; Flisiak, R.; Kao, J.‐H.; Chuang, W.‐L.; Streinu‐Cercel, A.; Tabak, F.; Calistru, P.; Goeser, T.; Rasenack, J.; Horban, A.; Davis, G. L.; Alberti, A.; Mazzella, G.; Pol, S.; Orsenigo, R.; Brass, C.
Journal:
Journal of viral hepatitis
Issue:
Volume 22:Issue 7(2015)
Page Start:
596
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Comparison of community‐onset healthcare‐associated and hospital‐acquired urinary infections caused by extended‐spectrum beta‐lactamase‐producing Escherichia coli and antimicrobial activities. Issue 7 (16th February 2015)

Authors:
Saltoglu, N.; Karali, R.; Yemisen, M.; Ozaras, R.; Balkan, I. I.; Mete, B.; Tabak, F.; Mert, A.; Hondur, N.; Ozturk, R.
Journal:
International journal of clinical practice
Issue:
Volume 69:Issue 7(2015)
Page Start:
766
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Hepatitis B core-related antigen levels are associated with response to entecavir and peginterferon add-on therapy in hepatitis B e antigen–positive chronic hepatitis B patients. (June 2016)

Authors:
van Campenhout, M.J.H.; Brouwer, W.P.; van Oord, G.W.; Xie, Q.; Zhang, Q.; Zhang, N.; Guo, S.; Tabak, F.; Streinu-Cercel, A.; Wang, J.; Pas, S.D.; Sonneveld, M.J.; de Knegt, R.J.; Boonstra, A.; Hansen, B.E.; Janssen, H.L.A.
Journal:
Clinical microbiology and infection
Issue:
Volume 22:Number 6(2016)
Page Start:
571.e5
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Loss of intrahepatic HBsAg expression predicts sustained response to peginterferon and is reflected by pronounced serum HBsAg decline. Issue 12 (20th January 2014)

Authors:
Arends, P.; Rijckborst, V.; Zondervan, P. E.; Buster, E.; Cakaloglu, Y.; Ferenci, P.; Tabak, F.; Akarca, U. S.; Simon, K.; Sonneveld, M. J.; Hansen, B. E.; Janssen, H. L. A.
Journal:
Journal of viral hepatitis
Issue:
Volume 21:Issue 12(2014)
Page Start:
897
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Peginterferon add‐on results in more HBsAg decline compared to monotherapy in HBeAg‐positive chronic hepatitis B patients. Issue 6 (25th September 2015)

Authors:
Brouwer, W. P.; Sonneveld, M. J.; Xie, Q.; Guo, S.; Zhang, N.; Zeuzem, S.; Tabak, F.; Zhang, Q.; Simon, K.; Akarca, U. S.; Streinu‐Cercel, A.; Hansen, B. E.; Janssen, H. L. A.
Journal:
Journal of viral hepatitis
Issue:
Volume 23:Issue 6(2016)
Page Start:
419
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Polymorphisms of HLA‐DP are associated with response to peginterferon in Caucasian patients with chronic hepatitis B. Issue 7 (11th August 2014)

Authors:
Brouwer, W. P.; Sonneveld, M. J.; Tabak, F.; Simon, K.; Cakaloglu, Y.; Akarca, U. S.; Zeuzem, S.; Ferenci, P.; Heathcote, J. E.; de Knegt, R. J.; Boonstra, A.; Hansen, B. E.; Janssen, H. L. A.
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 40:Issue 7(2014)
Page Start:
811
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Predictors of response to tenofovir disoproxil fumarate plus peginterferon alfa‐2a combination therapy for chronic hepatitis B. Issue 9 (15th September 2016)

Authors:
Marcellin, P.; Ahn, S. H.; Chuang, W.‐L.; Hui, A. J.; Tabak, F.; Mehta, R.; Petersen, J.; Lee, C.‐M.; Ma, X.; Caruntu, F. A.; Tak, W. Y.; Elkhashab, M.; Lin, L.; Wu, G.; Martins, E. B; Charuworn, P.; Yee, L. J.; Lim, S. G.; Foster, G. R.; Fung, S.
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 44:Issue 9(2016)
Page Start:
957
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗